Novel role of a family of major facilitator transporters in biofilm development and virulence of Candida albicans

Biochemical Journal

Volumn 460, Issue 2, 2014, Pages 223-235

  Shah, Abdul Haseeb ^a   Singh, Ashutosh ^a   Dhamgaye, Sanjiveeni ^a   Chauhan, Neeraj ^b   Vandeputte, Patrick ^c,f   Suneetha, Korivi Jyothiraj ^d   Kaur, Rupinder ^d   Mukherjee, Pranab K ^e   Chandra, Jyotsna ^e   Ghannoum, Mahmoud A ^e   Sanglard, Dominique ^c   Goswami, Shyamal K ^a   Prasad, Rajendra ^a  

^a JAWAHARLAL NEHRU UNIVERSITY   (India)

^b PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^d CENTRE FOR DNA FINGERPRINTING AND DIAGNOSTICS   (India)

^e CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITÉ D'ANGERS   (France)

Author keywords

Candida Albicans; Lipid homoeostasis; Quinidine drug resistance (QDR) transporters; Virulence

Indexed keywords

CARRIER PROTEIN; GREEN FLUORESCENT PROTEIN; PROTEIN QDR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOFILM; CANDIDA ALBICANS; CONTROLLED STUDY; FEMALE; FUNGAL VIRULENCE; FUNGUS GROWTH; GENE; GENE DELETION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HOMEOSTASIS; LIPID COMPOSITION; LIPIDOMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; QDR GENE; QDR1 GENE; QDR2 GENE; QDR3 GENE; QUORUM SENSING;

ANIMALS; BIOFILMS; CANDIDA ALBICANS; CANDIDIASIS; DRUG RESISTANCE, FUNGAL; GENES, FUNGAL; MEMBRANE LIPIDS; MEMBRANE MICRODOMAINS; MEMBRANE TRANSPORT PROTEINS; MICE; QUORUM SENSING; VIRULENCE;

EID: 84900512899     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20140010     Document Type: Article

References (68)

1. Ostrosky-Zeichner, L., Casadevall, A., Galgiani, J. N., Odds, F. C. and Rex, J. H. (2010) An insight into the antifungal pipeline: selected new molecules and beyond. Nat. Rev. Drug Discov. 9, 719-727 CrossRef PubMed
2. Odds, F. C., Brown, A. J. and Gow, N. A. (2003) Antifungal agents: mechanisms of action. Trends Microbiol. 11, 272-279 CrossRef PubMed
3. Morio, F., Loge, C., Besse, B., Hennequin, C. and Le Pape, P. (2010) Screening for amino acid substitutions in the Candida albicans Erg11 protein of azole-susceptible and azole-resistant clinical isolates: new substitutions and a review of the literature. Diagn. Microbiol. Infect. Dis. 66, 373-384 CrossRef PubMed
4. Flowers, S. A., Barker, K. S., Berkow, E. L., Toner, G., Chadwick, S. G., Gygax, S. E., Morschhäuser, J. and Rogers, P. D. (2012) Gain-of-function mutations in UPC2 are a frequent cause of ERG11upregulation in azole-resistant clinical isolates of Candida albicans. Eukaryot. Cell 11, 1289-1299 CrossRef PubMed
5. Cannon, R. D., Lamping, E., Holmes, A. R., Niimi, K., Baret, P. V., Keniya, M. V., Tanabe, K., Niimi, M., Goffeau, A. and Monk, B. C. (2009) Efflux-mediated antifungal drug resistance. Clin. Microbiol. Rev. 22, 291-321 CrossRef PubMed
6. + transport. Eukaryot. Cell 6, 443-453 CrossRef PubMed
7. Walker, L. A., Gow, N. A. and Munro, C. A. (2010) Fungal echinocandin resistance. Fungal Genet. Biol. 47, 117-126 CrossRef PubMed
8. Mukherjee, P. K. and Chandra, J. (2004) Candida biofilm resistance. Drug Resist. Updates 7, 301-309 CrossRef PubMed
9. Ramage, G., Bachmann, S., Patterson, T. F., Wickes, B. L. and López-Ribot, J. L. (2002) Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms. J. Antimicrob. Chemother. 49, 973-980 CrossRef PubMed
10. Prasad, R., De Wergifosse, P., Goffeau, A. and Balzi, E. (1995) Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungals. Curr. Genet. 27, 320-329 CrossRef PubMed
11. Sanglard, D., Ischer, F., Monod, M. and Bille, J. (1997) Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene. Microbiology 143, 405-416 CrossRef PubMed
12. Prasad, R. and Kapoor, K. (2005) Multidrug resistance in yeast Candida. Int. Rev. Cytol. 242, 215-248 CrossRef PubMed
13. Gaur, M., Puri, N., Manoharlal, R., Rai, V., Mukhopadhayay, G., Choudhury, D. and Prasad, R. (2008) MFS transportome of the human pathogenic yeast Candida albicans. BMC Genomics 9, 579 CrossRef PubMed
14. Nunes, P. A., Tenreiro, S. and Sá-Correia, I. (2001) Resistance and adaptation to quinidine in Saccharomyces cerevisiae: role of QDR1(YIL120w), encoding a plasma membrane transporter of the major facilitator superfamily required for multidrug resistance. Antimicrob. Agents Chemother. 45, 1528-1534 CrossRef PubMed
15. Vargas, R. C., Tenreiro, S., Teixeira, M. C., Fernandes, A. R. and Śa-Correia, I. (2004) Saccharomyces cerevisiae multidrug transporter Qdr2p (Yil121wp): localization and function as a quinidine resistance determinant. Antimicrob. Agents Chemother. 48, 2531-2537 CrossRef PubMed
16. Tenreiro, S., Vargas, R. C., Teixeira, M. C., Magnani, C. and Sá-Correia, I. (2005) The yeast multidrug transporter Qdr3 (Ybr043c): localization and role as a determinant of resistance to quinidine, barban, cisplatin, and bleomycin. Biochem. Biophys. Res. Commun. 327, 952-959 CrossRef PubMed
17. Ŕios, G., Cabedo, M., Rull, B., Yenush, L., Serrano, R. and Mulet, J. M. (2013) Role of the yeast multidrug transporter Qdr2 in cation homeostasis and the oxidative stress response. FEMS Yeast Res. 13, 97-106 CrossRef PubMed
18. Vargas, R. C., Garćia-Salcedo, R., Tenreiro, S., Teixeira, M. C., Fernandes, A. R., Ramos, J. and Sá-Correia, I. (2007) Saccharomyces cerevisiae multidrug resistance transporter Qdr2 is implicated in potassium uptake, providing a physiological advantage to quinidine-stressed cells. Eukaryot. Cell 6, 134-142 CrossRef PubMed
19. + antiporter Qdr3 and the transcription factors Yap1 and Gcn4. Microbiology 157, 945-956 CrossRef PubMed
20. + antiporter CgQdr2 confers imidazole drug resistance, being activated by transcription factor CgPdr1. Antimicrob. Agents Chemother. 57, 3159-3167 CrossRef PubMed
21. Dhamgaye, S., Devaux, F., Manoharlal, R., Vandeputte, P., Shah, A. H., Singh, A., Blugeon, C., Sanglard, D. and Prasad, R. (2012) In vitro effect of malachite green on Candida albicans involves multiple pathways and transcriptional regulators UPC2 and STP2. Antimicrob. Agents Chemother. 56, 495-506 CrossRef PubMed
22. Mukhopadhyay, K., Kohli, A. and Prasad, R. (2002) Drug susceptibilities of yeast cells are affected by membrane lipid composition. Antimicrob. Agents Chemother. 46, 3695-3705 CrossRef PubMed
23. Clinical and Laboratory Standards Institute (CLSI) (2008) Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts, III edition, Clinical and Laboratory Standards Institute, Wayne
24. Ivnitski-Steele, I., Holmes, A. R., Lamping, E., Monk, B. C., Cannon, R. D. and Sklar, L. A. (2009) Identification of Nile red as a fluorescent substrate of the Candida albicans ATP-binding cassette transporters Cdr1p and Cdr2p and the major facilitator superfamily transporter Mdr1p. Anal. Biochem. 394, 87-91 CrossRef PubMed
25. Shukla, S., Saini, P., Smriti Jha, S., Ambudkar, S. V. and Prasad, R. (2003) Functional characterization of Candida albicansABC transporter Cdr1p. Eukaryot. Cell 2, 1361-1375 CrossRef PubMed
26. Reuss, O., Vik, A., Kolter, R. and Morschhauser, J. (2004) The SAT1 flipper, an optimized tool for gene disruption in Candida albicans. Gene 341, 119-127 CrossRef PubMed
27. Coste, A. T., Karababa, M., Ischer, F., Bille, J. and Sanglard, D. (2004) TAC1, transcriptional activator of CDR genes, is a new transcription factor involved in the regulation of Candida albicans ABC transporters CDR1 and CDR2. Eukaryot. Cell 3, 1639-1652 CrossRef PubMed
28. Eddouzi, J., Parker, J. E., Vale-Silva, L. A., Coste, A., Ischer, F., Kelly, S., Manai, M. and Sanglard, D. (2013) Molecular mechanisms of drug resistance in clinical Candida species isolated from Tunisian hospitals. Antimicrob. Agents Chemother. 57, 3182-3193 CrossRef PubMed
29. Decottignies, A., Grant, A. M., Nichols, J. W., de Wet, H., McIntosh, D. B. and Goffeau, A. (1998) ATPase and multidrug transport activities of the overexpressed yeast ABC protein Yor1p. J. Biol. Chem. 273, 12612-12622 CrossRef PubMed
30. Lamping, E., Monk, B. C, Niimi, K., Holmes, A. R., Tsao, S., Tanabe, K., Niimi, M., Uehara, Y and Cannon, R. D. (2007) Characterization of three classes of membrane proteins involved in fungal azole resistance by functional hyperexpression in Saccharomyces cerevisiae. Eukaryot. Cell 6, 1150-1165 CrossRef PubMed
31. Pasrija, R., Panwar, S. L. and Prasad, R. (2008) Multidrug transporters CaCdr1p and CaMdr1p of Candida albicans display different lipid specificities: both ergosterol and sphingolipids are essential for targeting of CaCdr1p to membrane rafts. Antimicrob. Agents Chemother. 52, 694-704 CrossRef PubMed
32. Boyle, E. I., Weng, S., Gollub, J., Jin, H., Botstein, D., Cherry, J. M. and Sherlock, G. (2004) GO:TermFinder-open source software for accessing Gene Ontology information and finding significantly enriched Gene Ontology terms associated with a list of genes. Bioinformatics 20, 3710-3715 CrossRef PubMed
33. Prasad, T, Saini, P., Gaur, N. A., Vishwakarma, R. A., Khan, L. A., Haq, Q. M. and Prasad, R. (2005) Functional analysis of CaIPT1, a sphingolipid biosynthetic gene involved in multidrug resistance and morphogenesis of Candida albicans. Antimicrob. Agents Chemother. 49, 3442-3452 CrossRef PubMed
34. Chandra, J., Mukherjee, P. K. and Ghannoum, M. A. (2008) In vitro growth and analysis of Candida biofilms. Nat. Protoc. 3, 1909-1924 CrossRef PubMed
35. Desai, C, Mavrianos, J. and Chauhan, N. (2011) Candida albicans SRR1, a putative two-component response regulator gene, is required for stress adaptation, morphogenesis, and virulence. Eukaryot. Cell 10, 1370-1374 CrossRef PubMed
36. Singh, A., Prasad, T, Kapoor, K., Mandal, A., Roth, M., Welti, R. and Prasad, R. (2010) Phospholipidome of Candida: each species of Candida has distinctive phospholipid molecular species. OMICS 14, 665-677 CrossRef PubMed
37. Bligh, E.G. and Dyer, W.J. (1959) A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37, 911-917 CrossRef PubMed
38. Singh, A. and Prasad, R. (2011) Comparative lipidomics of azole sensitive and resistant clinical isolates of Candida albicans reveals unexpected diversity in molecular lipid imprints. PLoS ONE 6, e19266 CrossRef PubMed
39. Insenser, M., Nombela, C, Molero, G. and Gil, C. (2006) Proteomic analysis of detergent-resistant membranes from Candida albicans. Proteomics 6, S74-S81 CrossRef PubMed
40. Bagnat, M., Keranen, S., Shevchenko, A., Shevchenko, A. and Simons, K. (2000) Lipid rafts function in biosynthetic delivery of proteins to the cell surface in yeast. Proc. Natl. Acad. Sci. U.S.A. 97, 3254-3259 CrossRef PubMed
41. Levental, I., Lingwood, D., Grzybek, M., Coskun, U. and Simons, K. (2010) Palmitoylation regulates raft affinity for the majority of integral raft proteins. Proc. Natl. Acad. Sci. U.S.A. 107, 22050-22054 CrossRef PubMed
42. Smotrys J, E. and Linder, M, E. (2004) Palmitoylation of intracellular signaling proteins: regulation and function. Annu. Rev. Biochem. 73, 559-587 CrossRef PubMed
43. Peyton, B. M. (1996) Effects of shear stress and substrate loading rate on Pseudomonas aeruginosa biofilm thickness and density. Water Res. 30, 29-36 CrossRef
44. Kohli, A., Smriti Mukhopadhyay K, Rattan, A. and Prasad, R. (2002) In vitro low-level resistance to azoles in Candida albicans is associated with changes in membrane lipid fluidity and asymmetry. Antimicrob. Agents Chemother. 46, 1046-1052 CrossRef PubMed
45. Pasrija, R., Prasad, T. and Prasad, R. (2005) Membrane raft lipid constituents affect drug susceptibilities of Candida albicans. Biochem. Soc. Trans. 33, 1219-1223 CrossRef PubMed
46. Seneviratne, C. J., Jin, L and Samaranayake, L. P. (2008) Biofilm lifestyle of Candida: a mini review. Oral Dis. 14, 582-590 CrossRef PubMed
47. Chen, Y L, Montedonico, A. E., Kauffman, S., Dunlap, J. R., Menn, F. M. and Reynolds, T. B. (2010) Phosphatidylserine synthase and phosphatidylserine decarboxylase are essential for cell wall integrity and virulence in Candida albicans. Mol. Microbiol. 75, 1112-1132 CrossRef PubMed
48. Noble, S. M., French, S., Kohn, L. A., Chen, V. and Johnson, A. D. (2010) Systematic screens of a Candida albicanshomozygous deletion library decouple morphogenetic switching and pathogenicity. Nat. Genet. 42, 590-598 CrossRef PubMed
49. Lattif, A. A., Mukherjee, P. K., Chandra, J., Roth, M. R., Welti, R., Rouabhia, M. and Ghannoum, MA. (2011) Lipidomics of Candida albicans biofilms reveals phase-dependent production of phospholipid molecular classes and role for lipid rafts in biofilm formation. Microbiology 157, 3232-3242 CrossRef PubMed
50. Nickerson, K. W., Atkin, A. L. and Hornby, J. M. (2006) Quorum sensing in dimorphic fungi: farnesol and beyond. Appl. Environ. Microbiol. 72, 3805-3813 CrossRef PubMed
51. Han, T. L, Cannon, R. D. and Villas-Bôas, S. G. (2011) The metabolic basis of Candida albicans morphogenesis and quorum sensing. Fungal Genet. Biol. 48, 747-763 CrossRef PubMed
52. Navarathna, D. H., Hornby, J. M., Krishnan, N., Parkhurst, A., Duhamel, G. E. and Nickerson, K. W. (2007) Effect of farnesol on a mouse model of systemic candidiasis, determined by use of a DPP3 knockout mutant of Candida albicans. Infect. Immun. 75, 1609-1618 CrossRef PubMed
53. Bishop, A. C., Ganguly, S., Solis, N. V., Cooley, B. M., Jensen-Seaman, M. I., Filler, S. G., Mitchell, A. P. and Patton-Vogt, J. (2013) Glycerophosphocholine utilization by Candida albicans: role of the GIT3 transporter in virulence. J Biol. Chem. 288, 33939-33952 CrossRef PubMed
54. Paul, S., Diekema, D. and Moye-Rowley, W. S. (2013) Contributions of Aspergillus fumigatesATP-binding cassette transporter proteins to drug resistance and virulence. Eukaryot. Cell 12, 1619-1628 CrossRef PubMed
55. Mukherjee, P. K., Chandra, J., Kuhn, D. M. and Ghannoum, M. A. (2003) Mechanism of fluconazole resistance in Candida albicans biofilms: phase-specific role of efflux pumps and membrane sterols. Infect. Immun. 71, 4333-4340 CrossRef PubMed
56. Gácser, A., Stehr, F., Kröger, C., Kredics, L., Schäfer, W. and Nosanchuk, J. D. (2007) Lipase 8 affects the pathogenesis of Candida albicans. Infect. Immun. 75, 4710-4718 CrossRef PubMed
57. Trofa, D., Soghier, L., Long, C., Nosanchuk, J. D., Gacser, A. and Goldman, D. L. (2011) A rat model of neonatal candidiasis demonstrates the importance of lipases as virulence factors for Candida albicans and Candida parapsilosis. Mycopathologia 172, 169-178 CrossRef PubMed
58. Nagy, I., Filkor, K., Németh, T., Hamari, Z., Vágvö lgyi, C. and Gácser, A. (2011) In vitro interactions of Candida parapsilosis wild type and lipase deficient mutants with human monocyte derived dendritic cells. BMC Microbiol. 11, 122 CrossRef PubMed
59. Németh, T., Tóth, A., Szenzenstein, J., Horváth, P., Nosanchuk, J. D., Zsuzsanna, G., Tóth, R., Papp, C., Hamari, Z., Vágvölgyi, C. and Gácser, A. (2013) Characterization of virulence properties in the C. parapsilosis sensu lato species. PLoS ONE 8, e68704 CrossRef PubMed
60. Ghannoum, M. A. (2000) Potential role of phospholipases in virulence and fungal pathogenesis. Clin. Microbiol. Rev. 13, 122-143 CrossRef PubMed
61. Köhler, G. A., Brenot, A., Haas-Stapleton, E., Agabian, N., Deva, R. and Nigam, S. (2006) Phospholipase A2 and phospholipase B activities in fungi. Biochim. Biophys. Acta 1761, 1391-1399 CrossRef PubMed
62. Leidich, S. D., Ibrahim, A. S., Fu, Y., Koul, A., Jessup, C., Vitullo, J., Fonzi, W., Mirbod, F., Nakashima, S., Nozawa, Y. and Ghannoum, M. A. (1998) Cloning and disruption of caPLB1, a phospholipase B gene involved in the pathogenicity of Candida albicans. J. Biol. Chem. 273, 26078-26086 CrossRef PubMed
63. Theiss, S., Ishdorj, G., Brenot, A., Kretschmar, M., Lan, C. Y, Nichterlein, T., Hacker, J., Nigam, S., Agabian, N. and Köhler, G. A. (2006) Inactivation of the phospholipase B gene PLB5 in wild-type Candida albicansreduces cell-associated phospholipase A2 activity and attenuates virulence. Int. J. Med. Microbiol. 296, 405-420 CrossRef PubMed
64. Garćia-Sánchez, S., Aubert, S., Iraqui, I., Janbon, G., Ghigo, J. M. and d'Enfert, C. (2004) Candida albicansbiofilms: a developmental state associated with specific and stable gene expression patterns. Eukaryot. Cell 3, 536-545 CrossRef PubMed
65. Lan, C. Y., Newport, G., Murillo, L. A., Jones, T., Scherer, S., Davis, R. W. and Agabian, N. (2002) Metabolic specialization associated with phenotypic switching in Candida albicans. Proc. Natl. Acad. Sci. U.S.A. 99, 14907-14912 CrossRef PubMed
66. Finkel, J. S., Xu, W., Huang, D., Hill, E. M., Desai, J. V., Woolford, C. A., Nett, J. E., Taff, H., Norice, C. T., Andes, D. R. et al. (2012) Portrait of Candida albicans adherence regulators. PLoS Pathog. 8, e1002525 CrossRef PubMed
67. Sellam, A., Tebbji, F., Whiteway, M. and Nantel, A. (2012) A novel role for the transcription factor Cwt1p as a negative regulator of nitrosative stress in Candida albicans. PLoS ONE 7, e43956 CrossRef PubMed
68. Liu, T. T., Lee, R. E., Barker, K. S., Lee, R. E., Wei, L., Homayouni, R. and Rogers, P. D. (2005) Genome-wide expression profiling of the response to azole, polyene, echinocandin, and pyrimidine antifungal agents in Candida albicans. Antimicrob. Agents Chemother. 49, 2226-2236 CrossRef PubMed